Home »
Rulemaking » Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
Document ID: EPA-HQ-OAR-2006-0159-0026
Document Type: Public Submission
Agency: Environmental Protection Agency
Received Date: November 01 2006, at 01:58 PM Eastern Standard Time
Date Posted: November 9 2006, at 12:00 AM Eastern Standard Time
Comment Start Date: November 3 2006, at 07:49 AM Eastern Standard Time
Comment Due Date: December 4 2006, at 11:59 PM Eastern Standard Time
This document contains CBI and is not available online or from the EPA Docket Center. Please contact the Document Control Officer listed in the Federal Register.
Attachments:
Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
Title: Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
Abstract: This document contains CBI and is not available online or from the EPA Docket Center. Please contact the Document Control Officer listed in the Federal Register.
Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
This is comment on Proposed Rule
Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007
View Comment
Attachments:
Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
Title:
Placeholder for CONFIDENTIAL letter received by EPA from Robert M. Sussman of Latham and Watkins, LLC, counsel for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on October 13, 2006.
Abstract:
This document contains CBI and is not available online or from the EPA Docket Center. Please contact the Document Control Officer listed in the Federal Register.
Related Comments
View AllPublic Submission Posted: 11/06/2006 ID: EPA-HQ-OAR-2006-0159-0025
Dec 04,2006 11:59 PM ET
Public Submission Posted: 11/09/2006 ID: EPA-HQ-OAR-2006-0159-0026
Dec 04,2006 11:59 PM ET
Public Submission Posted: 11/14/2006 ID: EPA-HQ-OAR-2006-0159-0028
Dec 04,2006 11:59 PM ET
Public Submission Posted: 12/06/2006 ID: EPA-HQ-OAR-2006-0159-0030
Dec 04,2006 11:59 PM ET
Public Submission Posted: 12/06/2006 ID: EPA-HQ-OAR-2006-0159-0031
Dec 04,2006 11:59 PM ET